Aurinia Pharmaceuticals Inc. reports

Company location: Edmonton, Alberta, Canada
Fiscal year end: 31 December

Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
40-F
6-K

SEC filing history

Showing 1-7 of 7 matching filings.

Per page

25

Current page

1

40-F File 001-36421

40-F

Filing date: 05 Mar 2020
Reporting date: 31 Dec 2019
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

40-F File 001-36421

40-F

Filing date: 19 Mar 2019
Reporting date: 31 Dec 2018
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

40-F File 001-36421

40-F

Filing date: 15 Mar 2018
Reporting date: 31 Dec 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

40-F File 001-36421

FORM 40-F

Filing date: 09 Mar 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

40-F File 001-36421

ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015

Filing date: 18 Mar 2016
Reporting date: 31 Dec 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

40-F/A File 001-36421

AMENDMENT NO. 1 TO FORM 40-F

Filing date: 15 May 2015
Reporting date: 31 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

40-F File 001-36421

FORM 40-F

Filing date: 30 Mar 2015
Reporting date: 31 Dec 2014
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .